When using the global health expenditure data as a proxy for technology level, a comparison of the ARIMAX and ARIMA models shows that they are highly consistent in predicting the trend of disease burden, and both show that the global burden of diabetic nephropathy will continue to show an increasing trend in the future.
← all excerpts
Global burden of chronic kidney disease due to diabetes mellitus, 1990-2021, and projections to 2050.
1
—
—